First demonstration of universal cancer vaccine
New data shows 27% improved survival in the NIPU trial.
This author has yet to write their bio.Meanwhile lets just say that we are proud oslocancer contributed a whooping 279 entries.
New data shows 27% improved survival in the NIPU trial.
Her er de viktigste sakene i Statsbudsjettet 2024 for Oslo Cancer Clusters medlemmer.
SurViva is a Norwegian consultancy providing quality guidance for life science companies.
New Norwegian research in polygenic risk score
Oslo Cancer Cluster Innovation Park opened in May 2015.
The Innovation Park brings together the oncology-value chain from basic research to industry within the Oslo-area.
Our vision is to create Europe's leading environment for education, research and industry within oncology, shortening the development time of new cancer treatments.